Ali Golshayan
- Pulmonary and Respiratory Medicine top 1%
- Oncology top 2%
- Molecular Biology top 5%
- Cancer Research top 2%
- Immunology top 5%
- Co-authors
- Ronald M. BukowskiBrian I. RiniPaul ElsonLaura S. WoodToni K. ChoueiriJoanna IrelandRobert DreicerJames H. Finke
- Topics
- Renal cell carcinoma treatment (9 papers)Cancer Genomics and Diagnostics (6 papers)Bladder and Urothelial Cancer Treatments (4 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer
- Partner nations
- United StatesIndiaItaly
In The Last Decade
Ali Golshayan
17 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Pulmonary and Respiratory Medicine 2.1k
- Oncology 1.5k
- Molecular Biology 1.4k
- Cancer Research 892
- Immunology 760
Countries citing papers authored by Ali Golshayan
This map shows the geographic impact of Ali Golshayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Golshayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Golshayan more than expected).
Fields of papers citing papers by Ali Golshayan
This network shows the impact of papers produced by Ali Golshayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Golshayan. The network helps show where Ali Golshayan may publish in the future.
Co-authorship network of co-authors of Ali Golshayan
This figure shows the co-authorship network connecting the top 25 collaborators of Ali Golshayan. A scholar is included among the top collaborators of Ali Golshayan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Golshayan. Ali Golshayan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 25 | |
| 3 | 16 | |
| 4 | 17 | |
| 5 | 11 | |
| 6 | 18 | |
| 7 | 45 | |
| 8 | Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patientsbreakdown → | 690 |
| 9 | Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Studybreakdown → | 1525 |
| 10 | 4 | |
| 11 | 1 | |
| 12 | 3 | |
| 13 | 184 | |
| 14 | 389 | |
| 15 | 194 | |
| 16 | 4 | |
| 17 | 121 |
About Ali Golshayan
Ali Golshayan is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 17 papers that have together received 3.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (9 papers), Cancer Genomics and Diagnostics (6 papers) and Bladder and Urothelial Cancer Treatments (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.1k citations), Cancer Research (892 citations) and Oncology (1.5k citations). Ali Golshayan has collaborated with scholars based in United States, India and Italy. Frequent co-authors include Ronald M. Bukowski, Brian I. Rini, Paul Elson, Laura S. Wood, Toni K. Choueiri, Joanna Ireland, Robert Dreicer, James H. Finke, Patricia Rayman and Tina Cheng. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.